Literature DB >> 10078576

Histopathological study of placental bed biopsy in placenta previa.

R Biswas1, H Sawhney, R Dass, R K Saran, K Vasishta.   

Abstract

BACKGROUND: To study placental bed biopsy changes in placenta previa and normally implanted placenta. SUBJECT AND
METHOD: Fifty placental bed biopsies from 50 patients with placenta previa and 50 placental bed biopsies from normally implanted placenta were taken at cesarean section. Placental bed biopsy was stained with hematoxyline and eosin for histological examination. Both the groups were compared for trophoblastic invasion and vascular changes of placental bed spiral arteries. Statistical analysis was done by Chi-square test.
RESULTS: Placenta bed biopsy was representative in 42/50 (84%) biopsy samples of the study group (placenta previa) and 35/50 (70%) of the control group (normally located placenta). Trophoblastic giant cell migration into decidua was present in 100% of representative samples of both the groups while migration into myometrium was seen in 66.67% and 51.14% of samples of study and control group. Average number of trophoblastic giant cells per sample was significantly higher in placenta previa (decidua 41.3%, myometrium 52%) than the control group (decidua 17.4%; myometrium 14.5%). Trophoblastic giant cell infiltration into myometrial spiral arterioles was higher in placenta previa (81.83 cells per vessel). Percentage of myometrial spiral arterioles showing physiological changes was significantly higher in the study group (50.39%) compared to the control group (21.14%). Incidence of inflammatory cell infiltration was higher in the study group (42.86%). Hemorrhage into decidua and myometrium were seen in biopsy samples of the placenta previa.
CONCLUSION: Placenta previa is associated with significantly higher trophoblastic giant cell infiltration and physiological changes of the myometrial spiral arterioles.

Entities:  

Mesh:

Year:  1999        PMID: 10078576

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Changes in first trimester screening test parameters in pregnancies complicated by placenta previa and association with hyperemesis gravidarum.

Authors:  Fırat Tülek; Alper Kahraman; Salih Taşkın; Esra Özkavukçu; Feride Söylemez
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-12-01

2.  The effect of placenta previa on fetal growth and pregnancy outcome, in correlation with placental pathology.

Authors:  E Weiner; H Miremberg; E Grinstein; Y Mizrachi; L Schreiber; J Bar; M Kovo
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

3.  PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta†.

Authors:  Elisa T Zhang; Roberta L Hannibal; Keyla M Badillo Rivera; Janet H T Song; Kelly McGowan; Xiaowei Zhu; Gudrun Meinhardt; Martin Knöfler; Jürgen Pollheimer; Alexander E Urban; Ann K Folkins; Deirdre J Lyell; Julie C Baker
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

4.  Stereological analysis of human placenta in cases of placenta previa in comparison with normally implanted controls.

Authors:  Zahra Heidari; Nahid Sakhavar; Hamidreza Mahmoudzadeh-Sagheb; Tahmine Ezazi-Bojnourdi
Journal:  J Reprod Infertil       Date:  2015 Apr-Jun

5.  The effect prophylactic internal iliac artery balloon occlusion in patients with placenta previa or placental accreta spectrum: a systematic review and meta-analysis.

Authors:  Anisodowleh Nankali; Nader Salari; Mohsen Kazeminia; Masoud Mohammadi; Samira Rasoulinya; Melika Hosseinian-Far
Journal:  Reprod Biol Endocrinol       Date:  2021-03-04       Impact factor: 5.211

Review 6.  The possible correlation between the patient's immune tolerance level during cesaerean section and the incidence of subsequent emergency peripartum hysterectomy.

Authors:  Lukasz Wicherek; Krystna Galazka
Journal:  Clin Dev Immunol       Date:  2007

7.  Effect of Placenta Previa on Preeclampsia.

Authors:  Hao Ying; Yi Lu; Yi-Nuo Dong; De-Fen Wang
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.